Roswell Park Comprehensive Cancer Center: Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma
October 17, 2024
October 17, 2024
BUFFALO, New York, Oct. 17 (TNSres) -- The Roswell Park Comprehensive Cancer Center issued the following news release on Oct. 16, 2024:
* * *
Roswell Park's Dr. Kara Kelly co-developed study that could speed younger patients' access to this therapy
Highlights
* Nivolumab (Opdivo) superior to brentuximab vedotin (Adcetris) in combination
* Clinical trial results expected to change the standard of care
* Study . . .
* * *
Roswell Park's Dr. Kara Kelly co-developed study that could speed younger patients' access to this therapy
Highlights
* Nivolumab (Opdivo) superior to brentuximab vedotin (Adcetris) in combination
* Clinical trial results expected to change the standard of care
* Study . . .